Trending News Today: Eli Lilly Drug Meets Goal in Trials for Treatment of Type 1 Diabetes

Top news of the day from across the health care landscape

On Friday, the House passed a bipartisan legislation package to expand access to treatment for opioid abuse, encourage the development of alternative pain treatments, and curb the flow of illicit drugs into the United States, Politico reported. According to the article, the measure, which passed 396-14, combines more than 50 bills approved individually. The House package includes a number of bills aimed at increasing access to addiction treatment, as well as allowing nurse practitioners and physician assistants to prescribe buprenorphine, the article reported.

Eli Lilly announced that its drug Jardiance, along with insulin therapy, met the main goal of 2 trials testing it in patients with type 1 diabetes, Reuters reported. According to the article, the main goal of change in blood sugar levels for these patients on all doses of treatment had been met. Although it is not yet approved for type 1 diabetes, Jardiance is currently approved for use in adults with type 2 diabetes, the article reported.

Michigan Gov. Rick Snyder (R) signed a bill to impose work requirements on Medicaid recipients, The Hill reported. Although there are exemptions, those who meet the requirements will have to work for 80 hours per month, or be in school, job training, or substance abuse treatment, according to the article. If the plan is approved, Michigan would become the fifth state to add work mandates to its program, The Hill reported.